Related Experiment Videos
Lamicel does not promote induction of labour. A randomized controlled study.
1Department of Obstetrics and Gynaecology, Copenhagen University Hospital, Herlev, Denmark.
Summary
Lamicel, a synthetic cervical dilator, did not improve labor induction efficacy when used with oxytocin or prostaglandin E2. This randomized trial found no benefit for Lamicel in women with unripe cervices.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Clinical Trials
Background:
- Cervical ripening is crucial for labor induction.
- Osmotic dilators like Lamicel aim to facilitate cervical dilation.
- The efficacy of Lamicel as an adjunct to labor induction requires evaluation.
Purpose of the Study:
- To assess the efficacy of Lamicel as an adjunct to labor induction using intravenous oxytocin.
- To evaluate Lamicel's effectiveness when combined with vaginal prostaglandin E2 for labor induction.
- To compare outcomes in women receiving Lamicel versus standard induction methods.
Main Methods:
- A randomized controlled trial was conducted involving 91 pregnant women.
- Participants had an unripe cervix, necessitating labor induction.
- Lamicel was administered as a synthetic tent inserted into the cervical canal.
Main Results:
- No significant improvement in efficacy was observed in Lamicel groups compared to control groups.
- This finding held true for both oxytocin and prostaglandin E2 induction methods.
- Lamicel did not enhance cervical dilation or labor induction success rates.
Conclusions:
- Lamicel is not an effective adjunct for labor induction with oxytocin or prostaglandin E2.
- The use of osmotic dilators like Lamicel in this context showed no added benefit.
- Further research may be needed to explore alternative methods for cervical ripening.
Keywords:
BiologyCervical DilatationControl GroupsDeliveryDenmarkDeveloped CountriesEndocrine SystemEuropeEvaluationHormonesLaminaria Tents--administraction and dosageNorthern EuropeOxytocin--administraction and dosagePhysiologyPituitary HormonesPregnancyPregnancy OutcomesProstaglandins--administraction and dosageReproductionResearch MethodologyScandinaviaTreatment